Global Rheumatoid Arthritis Testing Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Rheumatoid Arthritis Testing market size was valued at US$ 2616 million in 2024 and is forecast to a readjusted size of USD 4180 million by 2031 with a CAGR of 6.9% during review period.

Rheumatoid arthritis is a long term severe disorder that directly affects the immune system of the human body. It is a serious disorder that comes with side effects such as swelling and inflammation around the affected area. Moreover, excessive pain is caused within body joints and organs of the body. The disease can affect several joints in the body, which in turn has led to a severe emphasis on the research and development of treatment options associated with the disease.

The rheumatoid arthritis (RA) testing market is experiencing growth, mainly due to the increase in the number of RA patients worldwide, the need for early diagnosis, and the continuous advancement of diagnostic technology. The main drivers of the market include technological advancement, the increase in the elderly population, the need for effective treatment options, and favorable health reimbursement policies. However, market growth also faces some challenges, such as test-related complications, the number of undiagnosed patients, and distrust of certain testing measures.

The top five players of rheumatoid arthritis testing in the world include Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthineers, and Werfen, with a total market share of more than 57%, of which the largest manufacturer is F. Hoffmann -La Roche, with over 16% market share. China is the global most important consumer market for rheumatoid arthritis testing, with a market share of about 46%. In terms of type, the market share of serological tests is over 50%. In the application field, the market share of hospitals and clinics is about 60%.

In addition, the RA treatment market is also showing a trend of diversified development, including the development of biological drugs and targeted therapies, which provide better efficacy and safety by precisely targeting specific immune system components and inflammatory pathways. However, safety issues related to RA treatment may hinder patient acceptance and limit market growth.

Overall, both the RA detection and treatment markets face huge growth potential, but also need to overcome some challenges, such as improving the reliability of detection, reducing costs, raising public awareness of RA, and ensuring the safety and effectiveness of treatment.

This report is a detailed and comprehensive analysis for global Rheumatoid Arthritis Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Rheumatoid Arthritis Testing market size and forecasts, in consumption value ($ Million), 2020-2031

Global Rheumatoid Arthritis Testing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Rheumatoid Arthritis Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Rheumatoid Arthritis Testing market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Rheumatoid Arthritis Testing

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Rheumatoid Arthritis Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthineers, Augurex Life Sciences, Svar Life Science AB, Aviva Systems Biology, Bio-Rad Laboratories, Thermo Fisher Scientific, Microdrop, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Rheumatoid Arthritis Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Serological Tests
Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
Imaging Tests
Others

Market segment by Application
Hospitals and Clinics
Diagnostic Centers
Others

Market segment by players, this report covers
Abbott Laboratories
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthineers
Augurex Life Sciences
Svar Life Science AB
Aviva Systems Biology
Bio-Rad Laboratories
Thermo Fisher Scientific
Microdrop
Werfen
Axis-Shield
Randox Laboratories
Guangzhou Leide Biosciences
Beijing Diagreat Biotechnologies

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Rheumatoid Arthritis Testing product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Rheumatoid Arthritis Testing, with revenue, gross margin, and global market share of Rheumatoid Arthritis Testing from 2020 to 2025.

Chapter 3, the Rheumatoid Arthritis Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Rheumatoid Arthritis Testing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Rheumatoid Arthritis Testing.

Chapter 13, to describe Rheumatoid Arthritis Testing research findings and conclusion.